{"transactions":[{"id":2995548,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":145586,"kind":"person","name":"Duckers Eric","position":1,"cik":"0001686154","reported_name":"Duckers Eric","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-11-03T23:06:24.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":8435,"price":2.01,"value":16954.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades ranging from $2.00 to $2.02 per share.  The price reported above reflects the weighted average per share sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares sold at each separate price."}],"balance_after":12088,"source":{"system":"sec-edgar","filing":"0001437749-20-022418","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920022418/rdgdoc.xml","form_type":"4"}},{"id":3095738,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":145586,"kind":"person","name":"Duckers Eric","position":1,"cik":"0001686154","reported_name":"Duckers Eric","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-02T01:15:51.000Z","date":"2020-06-30","kind":"tax_withholding","acquired":false,"shares":7154,"price":2.4,"value":17169.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on June 30, 2020 and does not represent a sale by the Reporting Person."}],"balance_after":20523,"source":{"system":"sec-edgar","filing":"0001437749-20-014424","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920014424/rdgdoc.xml","form_type":"4"}},{"id":3168659,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":145586,"kind":"person","name":"Duckers Eric","position":1,"cik":"0001686154","reported_name":"Duckers Eric","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-28T23:19:07.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 1/48th of the shares on May 24, 2020 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":25500,"derivative":{"exercise_price":3.43,"expiration_date":"2030-04-24","underlying":"Common Stock","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0001437749-20-008734","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920008734/rdgdoc.xml","form_type":"4"}},{"id":3168658,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":145586,"kind":"person","name":"Duckers Eric","position":1,"cik":"0001686154","reported_name":"Duckers Eric","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-28T23:19:07.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vest on June 30, 2020."}],"balance_after":27677,"source":{"system":"sec-edgar","filing":"0001437749-20-008734","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920008734/rdgdoc.xml","form_type":"4"}},{"id":3193551,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":145586,"kind":"person","name":"Duckers Eric","position":1,"cik":"0001686154","reported_name":"Duckers Eric","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-28T01:57:10.000Z","date":"2020-03-11","kind":"tax_withholding","acquired":false,"shares":1205,"price":3.6,"value":4338.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This share amount reflects the number of shares beneficially owned as of the filing date of this Form 4."}],"balance_after":10177,"source":{"system":"sec-edgar","filing":"0001437749-20-006393","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920006393/rdgdoc.xml","form_type":"4"}},{"id":3193550,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":145586,"kind":"person","name":"Duckers Eric","position":1,"cik":"0001686154","reported_name":"Duckers Eric","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-28T01:57:10.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":2947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vest on January 29, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This share amount reflects the number of shares beneficially owned as of the filing date of this Form 4."}],"balance_after":11382,"source":{"system":"sec-edgar","filing":"0001437749-20-006393","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774920006393/rdgdoc.xml","form_type":"4"}},{"id":3443908,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":145586,"kind":"person","name":"Duckers Eric","position":1,"cik":"0001686154","reported_name":"Duckers Eric","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Warrant (right to buy)","published_at":"2019-08-08T20:41:17.000Z","date":"2019-08-06","kind":"purchase","acquired":true,"shares":8435,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."}],"balance_after":8435,"derivative":{"exercise_price":6.3,"exercise_date":"2019-08-06","expiration_date":"2024-08-06","underlying":"Common Stock","underlying_shares":8435},"source":{"system":"sec-edgar","filing":"0001437749-19-016066","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774919016066/rdgdoc.xml","form_type":"4"}},{"id":3443907,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":145586,"kind":"person","name":"Duckers Eric","position":1,"cik":"0001686154","reported_name":"Duckers Eric","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Convertible promissory note","published_at":"2019-08-08T20:41:17.000Z","date":"2019-08-06","kind":"exercise","acquired":false,"price":0,"reported_value":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"reported_value","element":"transactionTotalValue","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."}],"derivative":{"exercise_price":3,"exercise_date":"2019-07-05","expiration_date":"2020-01-05","underlying":"Common Stock","underlying_shares":8435},"source":{"system":"sec-edgar","filing":"0001437749-19-016066","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774919016066/rdgdoc.xml","form_type":"4"}},{"id":3443906,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":145586,"kind":"person","name":"Duckers Eric","position":1,"cik":"0001686154","reported_name":"Duckers Eric","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Convertible promissory note","published_at":"2019-08-08T20:41:17.000Z","date":"2019-07-05","kind":"purchase","acquired":true,"price":25000,"reported_value":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"reported_value","element":"transactionTotalValue","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."}],"derivative":{"exercise_price":8,"exercise_date":"2019-07-05","expiration_date":"2020-01-05","underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001437749-19-016066","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774919016066/rdgdoc.xml","form_type":"4"}},{"id":3443905,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":145586,"kind":"person","name":"Duckers Eric","position":1,"cik":"0001686154","reported_name":"Duckers Eric","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-08T20:41:17.000Z","date":"2019-08-06","kind":"exercise","acquired":true,"shares":8435,"price":3,"value":25305.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued upon automatic conversion of a Convertible Promissory Note (the \"Note\") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering.  The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit."}],"balance_after":8435,"source":{"system":"sec-edgar","filing":"0001437749-19-016066","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774919016066/rdgdoc.xml","form_type":"4"}},{"id":3985584,"issuer":{"id":7752,"kind":"organization","name":"BioCardia, Inc.","symbol":"BCDA"},"owners":[{"id":145586,"kind":"person","name":"Duckers Eric","position":1,"cik":"0001686154","reported_name":"Duckers Eric","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-22T18:24:17.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":167880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 1/48th of the shares on March 1, 2018 and each monthly anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":167880,"derivative":{"exercise_price":2.6,"expiration_date":"2028-02-01","underlying":"Common stock","underlying_shares":167880},"source":{"system":"sec-edgar","filing":"0001437749-18-005230","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/925741/000143774918005230/rdgdoc.xml","form_type":"4"}}]}